The Most Lucrative Market for CROs in the Asia Pacific in 2015
The Most Lucrative Market for CROs in the Asia Pacific in 2015
RELEASE DATE
04-Mar-2015
04-Mar-2015
REGION
Asia Pacific
Asia Pacific
Research Code: 9A35-00-31-00-00
SKU: LS00067-AP-MR_16908
$500.00
Special Price $375.00 save 25 %
In stock
SKU
LS00067-AP-MR_16908
Description
This issue of vital signs highlights the APAC pharmaceutical and CRO landscape, attractiveness by phase of development, and lucrative markets to watch.
Table of Contents
This week's issue
Related Research
Popular Topics
This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. This research shows the latest developments in Russian biotechnology, defines key segments and emerging leaders, and outlines government policies and support mechanisms. The base year for the study is 2013 with a forecast period of 2014 to 2018.
No Index | No |
---|---|
Podcast | No |
Author | Sanjeev Kumar |
WIP Number | 9A35-00-31-00-00 |
Is Prebook | No |